Pelargonium sidoides extract for acute respiratory tract infections

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Timmer, Antje ^a,c   Günther, Judith ^b   Rücker, Gerta ^a   Motschall, Edith ^c   Antes, Gerd ^a   Kern, Winfried V ^c  

^a German Cochrane Center   (Germany)

^b Pharmafacts GmbH Research and Consulting in Drug Care   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PELARGONIUM SIDOIDES EXTRACT; PLACEBO;

BRONCHITIS; CLINICAL TRIAL; COCHRANE LIBRARY; COMMON COLD; DATA ANALYSIS; DATA BASE; DATA EXTRACTION; DRUG EFFICACY; DRUG SAFETY; EMBASE; GASTROINTESTINAL SYMPTOM; HUMAN; INFORMATION PROCESSING; MEDLINE; NONRESPONSE BIAS; OUTCOME ASSESSMENT; QUALITY CONTROL; RESPIRATORY TRACT INFECTION; REVIEW; RHINOSINUSITIS; RISK FACTOR; SINUSITIS; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TREATMENT FAILURE;

EID: 55049124692     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006323.pub2     Document Type: Review

References (66)

1. Anonymous 001 {unpublished data only} * Anonymous. Efficacy and tolerability of Pelargonium sidoides extract EPs 7630 in patients (1 to 18 years old) with acute bronchitis: a randomized, double-blind, placebo-controlled clinical trial. Study No. 701003.01.001. Summary of design, methods and results. Anonymous. Efficacy and tolerability of Pelargonium sidoides extract EPs 7630 in patients (1 to 18 years old) with acute bronchitis: a randomized, double-blind, placebo-controlled clinical trial. Study No. 701003.01.001. Supplement to the clinical study report (subgroup of patients less than 7 years old) 2007.
2. Anonymous 002 {unpublished data only} Anonymous. Efficacy and tolerability of Pelargonium sidoides extract EPs 7630 in patients (6 to 18 years old) with acute bronchitis. Study No. 701003.01.002. Biostatistical Short Report of the Interim Analysis 2007:1-16.
3. Anonymous 002 - 10 mg {unpublished data only} Anonymous. Efficacy and tolerability of Pelargonium sidoides extract EPs 7630 in patients (6 to 18 years old) with acute bronchitis. Study No. 701003.01.002. Biostatistical short report of the Interim Analysis 2007:1-16.
4. Anonymous 002 - 20 mg {unpublished data only} Anonymous. Efficacy and tolerability of Pelargonium sidoides extract EPs 7630 in patients (6 to 18 years old) with acute bronchitis. Study No. 701003.01.002. Biostatistical Short Report of the Interim Analysis 2007:1-16.
5. Anonymous 002 - 30 mg {unpublished data only} Anonymous. Efficacy and tolerability of Pelargonium sidoides extract EPs 7630 in patients (6 to 18 years old) with acute bronchitis. Study No. 701003.01.002. Biostatistical Short Report of the Interim Analysis 2007:1-16.
6. Anonymous 003 {unpublished data only} Anonymous. Efficacy and tolerability of Pelargonium sidoides extract EPs 7630 in patients (older than 18 years) with acute bronchitis. Study No. 701003.01.003. Biostatistical Short Report of the Interim Analysis 2007:1-16.
7. Anonymous 003 - 10 mg {unpublished data only} Anonymous. Efficacy and tolerability of Pelargonium sidoides extract EPs 7630 in patients (older than 18 years) with acute bronchitis. Study No. 701003.01.003. Biostatistical Short Report of the Interim Analysis 2007:1-16.
8. Anonymous 003 - 20 mg {unpublished data only} Anonymous. Efficacy and tolerability of Pelargoniumsidoides extract EPs 7630 in patients (older than 18 years) with acute bronchitis. Study No. 701003.01.003. Biostatistical Short Report of the Interim Analysis 2007:1-16.
9. Anonymous 003 - 30 mg {unpublished data only} Anonymous. Efficacy and tolerability of Pelargoniumsidoides extract EPs 7630 in patients (older than 18 years) with acute bronchitis. Study No. 701003.01.003. Biostatistical Short Report of the Interim Analysis 2007:1-16.
10. Anonymous 004 {unpublished data only} * Anonymous. Efficacy and tolerability of EPs 7630, a liquid herbal drug preparation from Pelargonium sidoides in patients (1-18 years old) suffering from acute bronchitis: a randomized, double-blind, placebo-controlled trial. Study No. 701003.01.004. Summary of design, methods and results. Anonymous. Efficacy and tolerability of Pelargonium sidoides extract EPs 7630 in patients (1 to 18 years old) with acute bronchitis: a randomized, double-blind, placebo-controlled clinical trial. Study No. 701003.01.004. Supplement to the clinical study report (subgroup of patients less than 7 years old).
11. Bachert unpublished {unpublished data only} Bachert C, Schapowal A, Kieser M, Malek F. Treatment of acute bacterial maxillary sinusitis with EPs 7630-solution: a randomised, double-blind, placebo-controlled trial. Focus Alternative Complementary Therapy. 2006; Vol. 11:4.
12. *Bachert C, Schapowal A, Malek AF, Kieser M. Treatment of acute bacterial maxillary sinusitis with the liquid preparation from Pelargonium sidoides EPs 7630: a randomized, double blind, placebo-controlled trial. supplied by manufacturer submitted for publication in 2006.
13. Chuchalin 2005 {published and unpublished data} * Chuchalin AG, Berman B, Lehmacher W. Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): a randomized, double blind, placebo-controlled trial. Explore 2005;1(6):437-45.
14. Golovatiouk A, Chuchalin AG. Efficacy of pelargonium sidoides preparation (Eps (R) 7630) in adults with acute bronchitis [Wirksamkeit eines Extraktes aus Pelargonium sidoides (EPs 7630) im Vergleich zu Placebo bei Patienten mit akuter Bronchitis]. Phytopharmaka. Vol. 7, Darmstadt: Steinkopff, 2002:3-12.
15. Lizogub 2007 {published data only} Lizogub VG, Riley DS, Heger M. Efficacy of Pelargonium Sidoides Preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial. Explore 2007;3(6):573-84.
16. Matthys 2007a {published and unpublished data} Matthys H, Heger M. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, multicentre, double-blind, placebo-controlled study. Current Medical Research and Opinion 2007;23(2):323-31.
17. Bachert 2005 {published data only (unpublished sought but not used)} Bachert C, Schapowal A. EPs 7630 (Extract from Pelargonium sidoides) is effective in the treatment of acute maxillary sinusitis - results from two randomized double blind placebo controlled trials [EPs 7630 (Extrakt aus Pelargonium sidoides) ist wirksam in der Behandlung der akuten Sinusitis maxillaris - Ergebnisse zweier doppelblinder placebokontrollierter Studien]. Kongressband Phytopharmaka Phytotherapie; S4. 2005.
18. Bereznoy 2003 {published data only} Bereznoy VV, Riley DS, Wassmer G, Heger M. Efficacy of extract of pelargonium sidoides in children with acute non-group a beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double blind, placebo-controlled trial. Alternative Therapies 2003;9(5):68-79.
19. Heger M, Bereznoy VV. Non streptokkokkal tonsillopharyngitis in children: efficacy of an extract of Pelargonium sidoides (EPs 7630) as compared to placebo [Nicht-streptokokkenbedingte Tonsillopharyngitis bei Kindern: Wirksamkeit eines Extraktes aus Pelargonium sidoides (EPs 7630) im Vergleich zu Placebo]. Phytopharmaka. Vol. 7, Darmstadt: Steinkopff, 2002:13-25.
20. Blochin 1999 {published data only} Blochin B, Haidvogel M, Heger M. Umckaloabo vs. acetylcysteine in the treatment of acute bronchitis in children [Umckaloabo im Vergleich mit Acetylcystein bei Kindern mit akuter Bronchitis]. Der Kassenarzt 1999;49:46-9.
21. Blochin 2000 {published data only} Blochin B, Heger M. Umckaloabo vs. symptomatic therapy for the treatment of acute non streptococcol tonsillitis [Umckaloabo vs. symptomatische. Therapie in der Behandlung der akuten Angina catarrhalis]. Päd 2000;6:2-8.
22. Dome 1996 {published data only} Dome L, Schuster R. Umckaloabo - a phytotherapeutic alternative for acute bronchitis in childhood? [Umckaloabo - eine phytotherapeutische Alternative bei akuter Bronchitis im Kindesalter]. Ärztezeitschrift für Naturheilverfahren 1996;37(3):216-22.
23. Haidvogl M, Heger M. Treatment effect and safety of EPs 7630-solution in acute bronchitis in childhood: report of a multicentre observational study. Phytomedicine 2007;14(Suppl 6):60-4.
24. Haidvogl 1996 {published data only} Haidvogl M, Schuster R, Heger M. Acute bronchitis in childhood. Multicenter study on the effectiveness and safety of the phytotherapeutic preparation Umckaloabo [Akute Bronchitis im Kindesalter. Multi-zenter Studie zur Wirksamkeit und Verträglichkeit des Phytotherapeutikums Umckaloabo]. Zeitschrift für Phytotherapie 1996;17:300-13.
25. Matthys 2003 {published data only} Matthys H, Eisebitt R, Seith B, Heger M. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. Phytomedicine 2003;10(Suppl IV):7-17.
26. Matthys 2007b {unpublished data only} Matthys H, Heger M. EPs 7630 solution - an effective therapeutic option in acute and exacerbating bronchitis. Phytomedicine (in press) 2007.
27. Ah-See 2007 Ah-See KW, Evans AS. Sinusitis and itsmanagement. British Medical Journal 2007;334:358-61.
28. Barrett 2007 Barrett B, Harahan B, Brown D, Zhang Z, Brown R. Sufficiently important difference for common cold: severity reduction. Annals of Family Medicine 2007;5(3):216-23.
29. Bent 1999 Bent S, Saint S, Vittinghoff E, Grady D. Antibiotics in acute bronchitis: a meta-analysis. American Journal of Medicine 1999;107:62-7.
30. Conrad 2007a Conrad A, Jung I, Tioua D, Lallemand C, Carrapatoso F, Engels I, et al.Extract of Pelargonium sidoides (EPs((R)) 7630) inhibits the interactions of group A-streptococci and host epithelia in vitro. Phytomedicine 2007;14(Suppl 6):52-9.
31. Conrad 2007b Conrad A, Hansmann C, Engels I, Daschner FD, Frank U. Extract of Pelargonium sidoides (EPs 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitro. Phytomedicine 2007;14(Suppl 6):46-51.
32. Conrad 2007c Conrad A, Kolodziej H, Schulz V. Pelargoniumsidoides- extract (EPs((R)) 7630): registration confirms efficacy and safety. Wiener Klinische Wochenschrift 2007;157(13-14):331-6.
33. de Boer 2007 de Boer HJ, Hagemann U, Bate J, Meyboom RH. Allergic reactions to medicines derived from pelargonium species. Drug Safety 2007;30(8):677-80.
34. De Sutter 2006 De Sutter A, Lemiengre M, Van Maele G, van Driel M, De Meyere M, Christiaens T, et al.Predicting prognosis and effect of antibiotic treatment in rhinosinusitis. Annals of Family Medicine 2006;4(6):486-93.
35. Fahey 1998 Fahey T, Stocks N, Thomas T. Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. British Medical Journal 1998;316:906-10.
36. Gonzales 2000 Gonzales R, Sande MA. Uncomplicated acute bronchitis. Annals of Internal Medicine 2000;133:981-91.
37. Gonzales 2001 Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR, et al.Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Annals of Internal Medicine 2001;37(6):690-7.
38. Goos 2006 Goos KH, Albrecht U, Schneider B. Efficacy and safety profile of a herbal drug containing nasturtium herb and horseradish root in acute sinusitis, acute bronchitis and acute urinary tract infection in comparison with other treatments in the daily practice/results of a prospective cohort study. Arzneimittelforschung 2006;56(3):249-57.
39. Goos 2007 Goos KH, Albrecht U, Schneider B. On-going investigations on efficacy and safety profile of a herbal drug containing nasturtium herb and horseradish root in acute sinusitis, acute bronchitis and acute urinary tract infection in children in comparison with other antibiotic treatments. Arzneimittelforschung 2007;57(4):238-46.
40. Gruenwald 2005 Gruenwald J, Graubaum HJ, Busch R. Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis. A double-blind, randomized, placebo-controlled clinical trial. Arzneimittelforschung 2005;55(11):669-76.
41. Guo 2006 Guo R, Canter PH, Ernst E. Herbal medicines for the treatment of rhinosinusitis: a systematic review. Otolaryngology - Head and Neck Surgery 2006;135(4):496-506.
42. Higgins 2005 Higgins JPT, Green S, editors. Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 6. In: The Cochrane Library, Issue 3. Chichester, UK: John Wiley & Sons, Ltd, 2005.
43. Kayser 1997 Kayser O, Kolodziej H. Antibacterial activity of extracts and constituents of Pelargoniumsidoides and Pelargoniumreniforme. Planta Medica 1997;63(6):508-10.
44. Kayser 2001 Kayser O, Kolodziej H, Kiderlen AF. Immunomodulatory principles of Pelargonium sidoides. Phytotherapy Research 2001;15(2):122-6.
45. Kolodziej 2003 Kolodziej H, Kayser O, Radtke OA, Kiderlen AF, Koch E. Pharmacological profile of extracts of Pelargonium sidoides and their constituents. Phytomedicine 2003;10(Suppl 4):18-24.
46. Kolodziej 2007 Kolodziej H, Kiderlen AF. In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs 7630. Phytomedicine 2007;14(Suppl 6):18-26.
47. Kristo 2005 Kristo A, Uhari M, Luotonen J, Ilkko E, Koivunen P, Alho OP. Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial. Acta Paediatrica 2005;94(9):1208-13.
48. Latte 2000 Latte KP, Kayser O, Tan N, Kaloga M, Kolodziej H. Unusual coumarin patterns of Pelargonium species forming the origin of the traditional herbal medicine umckaloabo. Zeitschrift für Naturforschung 2000;55c:528-33.
49. Linder 2003 Linder JA, Singer DE, Ancker M, Atlas SJ.Measures of health-related quality of life for adults with acute sinusitis. A systematic review. Journal of General Internal Medicine 2003;18:390-401.
50. Masood 2007 Masood A, Moumoulidis I, Panesar J. Acute rhinosinusitis in adults: an update on current management. Postgraduate Medical Journal 2007;83(980):402-8.
51. Melzer 2006 Melzer J, Saller R, Schapowal A, Brignoli R. Systematic review of clinical data with BNO-101 (Sinupret) in the treatment of sinusitis. Forschende Komplementärmedizin (Research in Complementary Medicine) 2006;13(2):78-87.
52. Neugebauer 2005 Neugebauer P, Mickenhagen A, Siefer O, Walger M. A new approach to pharmacological effects on ciliary beat frequency in cell cultures - exemplary measurements under Pelargonium sidoides extract (EPs 7630). Phytomedicine 2005;12(1-2):46-51.
53. Poole 2006 Poole PJ, Black PN. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD001287.pub2]
54. Roots 2004 Roots I, Arold G, Dienel A, Meng G, Wollny A, Bauer S. Placebo controlled double blind interaction study of Pelargoniumsidoides extract and penicilline V in healthy volunteers [Placebokontrollierte doppelblinde Interaktionsstudie mit Pelargonium-sidoides-Extrakt und Penicillin V bei gesunden Probanden]. Phytopharmaka und Phytotherapie - Forschung und Praxis (Conference proceedings). Berlin, 2004:22.
55. Schulz 2003 Schulz V, Kolodziej H. Umckaloabo. Deutsche Apotheker-Zeitung 2003;143(12):55-64.
56. Shah 2007 Shah SA, Sander S, White CM, Rinaldi M, Coleman CI. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infectious Diseases 2007;7(9):580.
57. Small 2007 Small CB, Bachert C, Lund VJ, Moscatello A, Nayak AS, Berger WE. Judicious antibiotic use and intranasal corticosteroids in acute rhinosinusitis. American Journal of Medicine 2007;120(4):289-94.
58. Smucny 2004a Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD000245.pub2]
59. Smucny 2004b Smucny J, Flynn C, Becker L, Glazier R. Beta2-agonists for acute bronchitis. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD001726.pub3]
60. Taylor 2005 Taylor P, Maalim S, Coleman S. The strange story of umckaloabo. The Pharmaceutical Journal 2005;275(24):790-2.
61. Wenzel 2006 Wenzel RP, Fowler AA. Acute Bronchitis. New England Journal of Medicine 2006;355:2125-30.
62. Wu 2005 Wu T, Chen X, Duan X, Juan N, Liu G, Qiao J, et al.Chinese medicinal herbs for acute bronchitis. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD004560.pub3]
63. Wu 2007 Wu T, Zhang J, Qiu Y, Xie L, Liu GJ. Chinese medicinal herbs for the common cold. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD004782.pub2]
64. Zabolotnyi 2007 Zabolotnyi DI, Kneis KC, Richardson A, Rettenberger R, Heger M, Kaszkin-Bettag M, et al. Efficacy of a complex homeopathic medication (Sinfrontal) in patients with acute maxillary sinusitis: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial. Explore (NY) 2007;3(2):98-109.
65. Zalmanovici 2007 Zalmanovici A, Yaphe J. Steroids for acute sinusitis. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD005149.pub2]
66. Zimmermann 1965 Zimmermann W. On the anticoaculant properties of the umckaloao drug [Über die gerinnungshemmende Wirkung der Umckaloabo Droge]. Ärztliche Forschung 1965;19(5):278-80.